Merck’s response to Ebola outbreaks
Along with international agencies and governments, Merck has played — and continues to play — a leadership role in responding to Ebola.
December 17, 2020
Ebola Zaire virus has had a devastating impact on the world and has proved itself to be a deadly and extremely contagious disease. Since its discovery in 1976, the global health community has been working towards stopping its spread and saving communities from its impact.
Along with international agencies and governments, Merck has played — and continues to play — a leadership role in responding to Ebola. Merck, in collaboration with our public and private global partners, remains committed to supporting current and future outbreak response efforts.
Ebola outbreak response efforts provide key learnings for the global community on the handling of public health crises, including pandemics. Thankfully we continue to make progress in the fight against Ebola.
Since 2014, Merck has provided cash donations to a number of organizations involved in Ebola relief and recovery efforts.
Funding helped support the transport of medical supplies to the region. Donated Merck products were also included in these shipments.
Funds went towards conducting an assessment in Sierra Leone to determine specific strategies to stop the spread of the Ebola virus and prevent future outbreaks. Merck also sent two infectious disease experts who specialize in infection control to join a team of other specialists to advise and conduct a rapid assessment of the response and relief efforts on the ground.
International Medical Corps
Funding helped build, staff and provide training on effective Ebola isolation units and referral systems at the Phebe and C.B. Dunbar Hospitals in Bong County, Liberia.
U.S. fund for Unicef
Funding supported UNICEF’s efforts focusing on controlling the outbreak, reinforcing and ensuring access to essential social services and scaling up prevention and preparedness activities.